1-9 of 9
neoadjuvant therapy
Close
Sort by
Journal Articles

Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Hasmukh Jain, Manju Sengar, Vasu Babu Goli, Jayashree Thorat, Prashant Tembhare, Dhanlaxmi Shetty, V. N. Avinash Bonda, Lingaraj Nayak, P. G. Subramanian, Bhausaheb Bagal, Nikhil Patkar, Neha Sharma, Himanshi Gupta, Sumeet Gujral
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3436–3444.
https://doi.org/10.1182/bloodadvances.2020003368
Published: 2021
Journal Articles

A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML

Clinical Trials & Observations
Emily F. Mason, Olga Pozdnyakova, Mikhail Roshal, Amir T. Fathi, Eytan M. Stein, P. Brent Ferrell, Aaron C. Shaver, Mark Frattini, Hongfang Wang, Lei Hua, Jimmy Mu, Sung Choe, Rengyi Xu, Caroline Almon, Michael Cooper, Richard M. Stone, Robert P. Hasserjian, Michael R. Savona
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2279–2283.
https://doi.org/10.1182/bloodadvances.2020003685
Published: 2021
Includes: Supplemental data
Journal Articles

Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma

Clinical Trials & Observations
Diego Villa, Laurie H. Sehn, Kerry J. Savage, Cynthia L. Toze, Kevin Song, Wendie D. den Brok, Ciara L. Freeman, David W. Scott, Alina S. Gerrie
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3486–3494.
https://doi.org/10.1182/bloodadvances.2020002068
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical developments in epigenetic-directed therapies in acute myeloid leukemia

Darren Pan, Raajit Rampal, John Mascarenhas
Journal: Blood Advances
Blood Adv (2020) 4 (5): 970–982.
https://doi.org/10.1182/bloodadvances.2019001245
Published: 2020
Journal Articles

Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

Clinical Trials & Observations
Reid W. Merryman, Natasha Edwin, Robert Redd, Jad Bsat, Matthew Chase, Ann LaCasce, Arnold Freedman, Caron Jacobson, David Fisher, Samuel Ng, Jennifer Crombie, Austin Kim, Oreofe Odejide, Matthew S. Davids, Jennifer R. Brown, Heather Jacene, Amanda Cashen, Nancy L. Bartlett, Neha Mehta-Shah, Armin Ghobadi, Brad Kahl, Robin Joyce, Philippe Armand, Eric Jacobsen
Journal: Blood Advances
Blood Adv (2020) 4 (5): 858–867.
https://doi.org/10.1182/bloodadvances.2019001355
Published: 2020
Includes: Supplemental data
Journal Articles

Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

Clinical Trials & Observations
Franziska Schramm, Udo zur Stadt, Martin Zimmermann, Norbert Jorch, Arnulf Pekrun, Arndt Borkhardt, Thomas Imschweiler, Holger Christiansen, Jörg Faber, Irene Schmid, Tobias Feuchtinger, Gerhard Beron, Monique L. den Boer, Rob Pieters, Martin A. Horstmann, Gritta E. Janka-Schaub, Gabriele Escherich
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3688–3699.
https://doi.org/10.1182/bloodadvances.2019000576
Published: 2019
Includes: Supplemental data
Journal Articles

The impact of response kinetics for multiple myeloma in the era of novel agents

Clinical Trials & Observations
Yuting Yan, Xuehan Mao, Jiahui Liu, Huishou Fan, Chenxing Du, Zengjun Li, Shuhua Yi, Yan Xu, Rui Lv, Wei Liu, Shuhui Deng, Weiwei Sui, Qi Wang, Dehui Zou, Jianxiang Wang, Tao Cheng, Fenghuang Zhan, Yu-Tzu Tai, Chenglu Yuan, Xin Du, Lugui Qiu, Kenneth C. Anderson, Gang An
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2895–2904.
https://doi.org/10.1182/bloodadvances.2019000432
Published: 2019
Includes: Supplemental data
Journal Articles

Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition

Clinical Trials & Observations
Matthew J. Pianko, Sean M. Devlin, Eric R. Littmann, Aisara Chansakul, Donna Mastey, Meghan Salcedo, Emily Fontana, Lilan Ling, Elizabet Tavitian, John B. Slingerland, Ann E. Slingerland, Annelie Clurman, Antonio L. C. Gomes, Ying Taur, Eric G. Pamer, Jonathan U. Peled, Marcel R. M. van den Brink, Ola Landgren, Alexander M. Lesokhin
Journal: Blood Advances
Blood Adv (2019) 3 (13): 2040–2044.
https://doi.org/10.1182/bloodadvances.2019032276
Published: 2019
Includes: Supplemental data
Journal Articles

Phthalides serve as potent modulators to boost fetal hemoglobin induction therapy for β-hemoglobinopathies

Wei-Ren Chen, Chia-Cheng Chou, Chia C. Wang
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1493–1498.
https://doi.org/10.1182/bloodadvances.2019031120
Published: 2019
Includes: Supplemental data